Interferon alfa-2b
- Generic Name
- Interferon alfa-2b
- Brand Names
- Intron A
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 98530-12-2
- Unique Ingredient Identifier
- 43K1W2T1M6
- Background
Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
- Indication
For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.
- Associated Conditions
- Chronic Hepatitis B Infection, Chronic Hepatitis C Virus (HCV) Infection, Condylomata Acuminata (External), Follicular Non-Hodgkin's Lymphoma, Hairy Cell Leukemia (HCL), Kaposi's Sarcoma, Malignant Melanoma
- Associated Therapies
- -
Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type
New TNBC treatment at Roswell Park achieves 66% complete remission without immune-related adverse events, using a combination of chemotherapy and immunotherapy.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath